Paper Review — Verify any paper quickly

What the authors did (concise)

• Surveyed FFPE human brain sections (temporal cortex primarily, some frontal and cerebellum for specific analyses) from multiple diagnostic cohorts (AD ± LATE N=35, AD+LBD N=9, LBD N=29, FTLD-tau N=20, FTLD-TDP N=15, FTLD-FUS N=5, LATE N=8, aged controls N=7; separate c9orf72 cerebellar cohort) and scored nucleolar cavities for amyloid character and protein content using Congo red, polarized light, protease resistance, and immunohistochemistry for Aβ, pTau, α-synuclein, pTDP-43, FUS, prion, poly(GA)/polyQ etc Methods and cohorts

Key findings (evidence linked)

1. Neuronal nucleolar cavities frequently contain Congo red positive amyloidlike deposits that are protease resistant and display three morphological stages consistent with a liquid to solid continuum (multiple small foci → combination → central aggresome) Congo red and aggregate morphologies
2. Protein composition is selective: Aβ, phosphorylated tau, α-synuclein and phosphorylated TDP-43 are found variably in nucleolar aggregates, while prion protein, polyQ, and dipeptide repeat proteins are generally absent from nucleoli (though some DPRs show perinucleolar signals) Protein specificity across cohorts
3. Correlative relationships: nucleolar pTau aggresomes increase with higher A and B neuropathology scores and associate with reduced DNA instability in AD neurons (authors interpret this as possibly protective), while nucleolar α-synuclein aggresomes are frequent in aged controls and decrease with advancing tau pathology (suggesting context dependent role) pTau correlations and DNA metrics
4. pTDP-43 nucleolar aggresomes are a distinctive feature of LATE (limbic predominant age-related TDP-43 encephalopathy) and correlate with A and B pathology burden in those cohorts; authors argue nucleolar sequestration patterns are age and pathology dependent rather than acting as universal seeds for cytoplasmic inclusions pTDP43 LATE association

Major strengths

• Human postmortem dataset spanning many diagnostic groups and standardized neuropathological staging increases clinical relevance Cohort breadth
• Multipronged histochemical validation: Congo red plus protease resistance and polarized light provide robust evidence that nucleolar deposits have amyloid characteristics rather than simple staining artefacts Amyloid validation
• Quantitative image analysis for rRNA and DNA levels (Fiji) and blinded region scoring improves objectivity of selected comparisons Image quantification

Key limitations and blindspots

• Cross sectional postmortem design cannot determine temporality or causality: are nucleolar aggregates protective responses, passive sinks, or pathogenic drivers? Authors acknowledge the limitation; functional evidence is lacking Study limitations acknowledged
• Antibody specificity and epitope masking in dense aggregates can bias detection: some proteoforms (e.g., oligomeric vs fibrillar, phosphoepitopes) may be missed or variably detected; prion negative results may reflect antibody choice (authors note lack of PrPSc-specific antibody) Antibody/detection caveats
• Sampling bias and regional heterogeneity: temporal cortex was primary focus; other regions may show different nucleolar behaviour; cases per subgroup vary (some small N e.g., FTLD-FUS N=5) limiting statistical power for rarer findings Cohort and region sampling limitations
• Functional readouts are indirect: rRNA immunofluorescence and DAPI quantify nucleolar rRNA signal and DNA respectively, but do not directly measure ribosome biogenesis, nucleolar protein turnover, translation activity, or the dynamics of aggregate assembly/disassembly Functional readout limits

Interpretation: reasonable, cautious, and testable

The authors carefully avoid overclaiming seeding roles for nucleolar aggregates and instead present a nuanced model: nucleolar A bodies form across aging and disease, and their protein composition and morphological stage correlate with disease type and burden; for some proteins (pTau) nucleolar aggresomes correlate with markers consistent with genomic stabilization in AD, whereas for others (α-synuclein) nucleolar sequestration is common in aged controls and declines with tauopathy, consistent with a context dependent, possibly protective role Authors interpretation

Potential biases to watch

• Postmortem interval and agonal state can alter nucleic acid and protein accessibility; authors state imaging acquisition kept constant, but biochemical decay could influence detection differentially across cohorts.
• Positive result and detection bias: easily stainable aggregates (Congo red positive) will be preferentially scored; more soluble or transient condensates may be underestimated.
• Funding and cohort origin: cohorts from a single brain bank increase consistency but may limit population diversity.

How to strengthen and falsify the model (concrete next steps)

1. Longitudinal in vivo or inducible models: inducible expression of aggregationprone proteins with nucleolar reporters to follow nucleolar A body kinetics and test whether nucleolar immobilization precedes or follows cytoplasmic aggregation.
2. Proteomics of microdissected nucleoli from cases with/without specific nucleolar aggresomes to define exact proteoforms and post translational modifications (mass spec should use denaturing protocols to capture insoluble fibrils).
3. Functional assays in human iPSC neurons: modulate nucleolar integrity (e.g., RNA Pol I inhibitors, nucleolin knockdown) and measure effects on DNA breaks, rRNA output, and cytoplasmic aggregate formation to directly test causality.
4. Use conformation specific antibodies and PrPSc specific reagents when testing prion localization to exclude false negatives.

Bottom line

This is a high quality, carefully executed descriptive human neuropathology study offering novel, plausible, and testable findings: nucleolar amyloidlike aggregates are widespread in human neurons and their protein composition and morphology vary with age and diagnostic category, with important implications for nucleolar biology in aging and neurodegeneration; however, causality remains unresolved and functional experiments are required to determine whether nucleolar aggregation is protective, detrimental, or both depending on context Authors concluding statements

Quick links and next actions

Author Review G M H Run AI Biology Analysis